Literature DB >> 20404980

Evaluation of six risk factors for the development of bacteremia in children with cancer and febrile neutropenia.

E J Asturias1, J E Corral, J Quezada.   

Abstract

Febrile neutropenia is a well-known entity in children with cancer, being responsible for the high risk for infection that characterizes this population. For this reason, cancer patients are hospitalized so that they can receive prophylactic care. Risk factors have been used to classify patients at a high risk for developing bacteremia. The present study evaluates whether those risk factors (C-reactive protein, hypotension, leukemia as the cancer type, thrombocytopenia, recent chemotherapy, and acute malnutrition) apply to patients at the Unidad Nacional de Oncología Pediátrica. We evaluated 102 episodes in 88 patients, in whom risk factors and blood cultures were tested. We observed no statistical relationship between the six risk factors and bacteremia. There was also no relationship between bacteremia and the simultaneous presence of two, three, or more risk factors. A significant relationship of C-reactive protein and platelet count with other outcome factors was observed.

Entities:  

Keywords:  C-reactive protein; Cancer; bacteremia; fever; leukemia; neutropenia; risk factors; thrombocytopenia

Year:  2010        PMID: 20404980      PMCID: PMC2854640          DOI: 10.3747/co.v17i2.453

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  18 in total

1.  2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Authors:  Walter T Hughes; Donald Armstrong; Gerald P Bodey; Eric J Bow; Arthur E Brown; Thierry Calandra; Ronald Feld; Philip A Pizzo; Kenneth V I Rolston; Jerry L Shenep; Lowell S Young
Journal:  Clin Infect Dis       Date:  2002-02-13       Impact factor: 9.079

2.  [Analysis of microorganisms isolated from febrile neutropenic children with neoplastic disease].

Authors:  Ilona Wojak; Eugenia Gospodarek
Journal:  Med Dosw Mikrobiol       Date:  2004

3.  Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever.

Authors:  M E Santolaya; A M Alvarez; A Becker; J Cofré; N Enríquez; M O'Ryan; E Payá; J Pilorget; C Salgado; J Tordecilla; M Varas; M Villarroel; T Viviani; M Zubieta
Journal:  J Clin Oncol       Date:  2001-07-15       Impact factor: 44.544

Review 4.  Pediatric cancer patients in clinical trials of sepsis: factors that predispose to sepsis and stratify outcome.

Authors:  Robert Tamburro
Journal:  Pediatr Crit Care Med       Date:  2005-05       Impact factor: 3.624

5.  Microbiological spectrum and susceptibility patterns of pathogens causing bacteraemia in paediatric febrile neutropenic oncology patients: comparison between two consecutive time periods with use of different antibiotic treatment protocols.

Authors:  D Greenberg; A Moser; P Yagupsky; N Peled; Y Hofman; J Kapelushnik; E Leibovitz
Journal:  Int J Antimicrob Agents       Date:  2005-06       Impact factor: 5.283

6.  "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia.

Authors:  R J Klaassen; T R Goodman; B Pham; J J Doyle
Journal:  J Clin Oncol       Date:  2000-03       Impact factor: 44.544

7.  Fever and neutropenia in children with solid tumors is similar in severity and outcome to that in children with leukemia.

Authors:  Ulker Koçak; Kenneth V I Rolston; Craig A Mullen
Journal:  Support Care Cancer       Date:  2002-01       Impact factor: 3.603

8.  Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia.

Authors:  M E Santolaya; A M Alvarez; C L Avilés; A Becker; J Cofré; N Enríquez; M O'Ryan; E Payá; C Salgado; P Silva; J Tordecilla; M Varas; M Villarroel; T Viviani; M Zubieta
Journal:  Clin Infect Dis       Date:  2002-08-23       Impact factor: 9.079

Review 9.  Bloodstream infections in cancer patients with febrile neutropenia.

Authors:  Ronald Feld
Journal:  Int J Antimicrob Agents       Date:  2008-09-07       Impact factor: 5.283

10.  The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.

Authors:  K G Lucas; A E Brown; D Armstrong; D Chapman; G Heller
Journal:  Cancer       Date:  1996-02-15       Impact factor: 6.860

View more
  5 in total

1.  Transient hyperglycaemia - an underestimated problem of paediatric oncohaematology.

Authors:  Ninela Irga; Malgorzata Mysliwiec; Marcelina Osak; Malgorzata Szmigiero-Kawko; Elzbieta Adamkiewicz-Drozynska; Radoslaw Jaworski
Journal:  Arch Med Sci       Date:  2012-09-08       Impact factor: 3.318

2.  Bacterial bloodstream infections and antimicrobial susceptibility pattern in pediatric hematology/oncology patients after anticancer chemotherapy.

Authors:  Naima A Al-Mulla; Saad J Taj-Aldeen; Sittana El Shafie; Mohammed Janahi; Abdullah A Al-Nasser; Prem Chandra
Journal:  Infect Drug Resist       Date:  2014-11-06       Impact factor: 4.003

3.  Clinical Epidemiology Characteristics and Etiology of Febrile Neutropenia in Children: Analysis of 421 Cases.

Authors:  Sang Ngoc Nguyen; Lam Tung Vu; Quang Van Vu; Tham Thi Tran; Vi Tuong Thi Dinh
Journal:  Hematol Rep       Date:  2022-08-01

4.  Alarming Antibiotic Resistance in Pediatric Oncology Patients: A Three-Year Prospective Cohort Study from Oman.

Authors:  Abeer Al Battashi; Bishara Al Harrassi; Nawal Al Maskari; Hilal Al Hashami; Salah Al Awaidy
Journal:  Infect Drug Resist       Date:  2022-07-25       Impact factor: 4.177

Review 5.  Update on Febrile Neutropenia in Pediatric Oncological Patients Undergoing Chemotherapy.

Authors:  Federica Cennamo; Riccardo Masetti; Prisca Largo; Alberto Argentiero; Andrea Pession; Susanna Esposito
Journal:  Children (Basel)       Date:  2021-11-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.